The St. Louis class action attorneys at Carey Danis & Lowe have been closely following the DePuy ASR settlement following the announcement of Johnson & Johnson and DePuy’s $2.5 billion deal. The latest in the DePuy ASR settlement involves the naming of a claims administrator to assist with the settlement process, and a document that more clearly outlines the deal’s three compensation packages.
The $2.5 billion settlement deal announced in November is estimated to settle approximately 8,000 of 12,000 DePuy ASR hip lawsuits filed across the country.
A federal court in Ohio named retired Judge James J. McMonigle as the claims administrator. The court also named three special masters to assist with the settlement process.
Thousands of DePuy lawsuits have been consolidated into the U.S. District Court for the Northern District of Ohio, which is the court managing the settlement process. The DePuy multidistrict litigation (MDL) is known as In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products MDL no. 2197.
The Ohio federal court also released a document with detailed information on benefit packages. According to the document, there are three compensation packages.
The first compensation package is called the base payment, which involves a $250,000 award. This award can be reduced depending upon a variety of factors, including weight and history of smoking.
The second compensation package applies only to those plaintiffs who have undergone surgical operations to remove and replace the DePuy ASR hip implant in both left and right hips. Those plaintiffs qualifying for this compensatory award will receive an additional $250,000. Unlike the base payment package, this benefit calls to pay the full $250,000 to the plaintiff, with no reductions for weight, history of smoking, and other health factors.
The third package, called the Extraordinary Injury Fund (EIF), will provide benefits to those plaintiffs who experienced significant health complications due to the DePuy ASR hip implant. These health complications and injuries include pulmonary embolism, deep vein thrombosis (DVT), infection, stroke, myocardial infarction, death, and any other injuries incurred during revision surgeries.
It is important to note that the current settlement deal does not prohibit plaintiffs from seeking compensation for their injuries relating to the hip implant in the future.
If you have any questions about the DePuy ASR settlement, please contact one of our DePuy ASR hip attorneys at Carey Danis & Lowe. Learn more about the settlement, discuss your legal options in a free initial consultation, and get assistance with filing a DePuy ASR hip lawsuit.
Concerns about metal-on-metal hip implants and health complications can be addressed to a Carey Danis & Lowe on-staff nurse. Our team of medical experts are available to provide you with the most accurate information about metal-on-metal hip implants.
Share your DePuy ASR hip story with Carey Danis & Lowe today. Call us at 800.721.2519, or submit a confidential personal injury claim form.
For the latest DePuy ASR settlement news, read the Carey Danis & Lowe personal injury litigation blog.References: Defective Medical Device litigation, Hip/Knee Replacement